Medicenna Therapeutics Corp (TSE:MDNA) has released an update. Medicenna Therapeutics Corp. has unveiled promising preclinical data from its BiSKIT and IL-2 Super Agonist programs, showcasing ...

A FORMER KwaZulu-Natal North Coast resident has had a prominent hand in breakthrough multi-cancer early detection test ...

Medicenna Therapeutics Corp. has unveiled promising preclinical data from its BiSKIT and IL-2 Super Agonist programs, showcasing potential breakthroughs in cancer treatment. Their novel therapies ...

Scientists have discovered a way to target elusive circular fragments of DNA that drive the survival of some of the most aggressive cancers, paving the way for future treatments.

Infinitopes' lead vaccine candidate ITOP1 is a novel, precision targeted, immunologically durable, "off-the-shelf" cancer vaccine ... checkpoint inhibitor co-treatment The Company's approach ...

Advances in Cancer Treatment: How cutting-edge treatments are changing outcomes Cancer treatment is undergoing a ...

Reseachers from WEHI (Melbourne, Australia) have found a new way to predict a subset of patients who are likely to become ...

without checkpoint inhibitor co-treatment The Company's approach utilises its AI/ML Precision Immunomics TM antigen discovery platform, capable of identifying best-in-class pools of hundreds of novel ...